Opterion Health closes oversubscribed financing round, securing CHF 6.5m, and announces changes to its Board of Directors
· Opterion Health secures CHF 6.5m commitments to fund ongoing preclinical and Phase I preparation activities to create a new standard in Peritoneal Dialysis (PD) · Financing round supported by private and institutional investors oversubscribed by over 60% · As part of this capital round, additional option capital in the magnitude of CHF 7.3m issued · Stefan Wohlfeil to step down from the Board of Directors · Jan-Anders Karlsson and Robert Leitz elected as new members of the Board of Directors Muttenz, Switzerland, 20 September 2023 – Opterion Health AG, a Swiss-based